Cardiac Biomarkers Market Soars: Non-Invasive Testing Drives Early Detection of Heart Diseases
Cardiac biomarkers, critical indicators of heart health measured via blood or bodily fluid tests, are reshaping cardiovascular diagnostics. These substances—including troponin, BNP (B-type natriuretic peptide), and CK-MB (creatine kinase-MB)—signal damage from conditions like myocardial infarction (MI) or heart failure, enabling timely interventions. As global cardiovascular disease...
0 Comments
0 Shares
46 Views